Welcome

MDMA Equivalency Exam

Description

We're so happy you're here!

If you've completed MAPS courses in MDMA-assisted therapy or equivalent programs, you possess a solid foundation in this transformative approach to mental health care. This equivalency exam is designed for those entering the MDMA-assisted therapy stream to ensure you have the necessary skills, competencies, and orientations to embark on the next phase of your learning journey: Practical Applications of MDMA.

Course Description

We're so happy you're here!

If you've completed MAPS courses in MDMA-assisted therapy or equivalent programs, you possess a solid foundation in this transformative approach to mental health care. This equivalency exam is designed for those entering the MDMA-assisted therapy stream to ensure you have the necessary skills, competencies, and orientations to embark on the next phase of your learning journey: Practical Applications of MDMA.

Prior to completing the equivalency exam, we will review some content and introduce some topics which may not have been covered in your previous learning which are central to the Numinus curriculum. We will begin by exploring the Numinus Care Model and therapeutic stance.

We will also spend time reviewing vital considerations for Preparation, Medicine, and Integration Sessions as well as assessment. This review will ensure that you possess a comprehensive understanding of the key stages and their interconnectedness.

We look forward to working with you on this next stage of your pathway.

Learning Outcomes

Upon successful completion of the exam, you will have demonstrated successful achievement of the course learning outcomes from Fundamentals of Psychedelic-Assisted Therapy, Applied Psychedelic-Assisted Therapy: Cases, Conditions, and Context, and Molecular Foundations of MDMA:

Introduction to Psychedelics

  1. Categorize psychedelics according to their shared properties, effects, and primary mechanism of action.
  2. Compare the outcomes of psychedelic-assisted therapy and traditional psychopharmacological therapy.
  3. Outline key historical events that have contributed to the development of psychedelic-assisted therapy.
  4. List key studies that have investigated the outcomes of psychedelic-assisted therapy.
  5. Describe the potential for risk of using psychedelic medicines inside and outside of a clinical setting.

Fundamentals of Psychedelic-Assisted Therapy

  1. Describe the unique vulnerabilities of clients participating in psychedelic-assisted therapy and cultivate the awareness and practices necessary to meet these vulnerabilities safely and ethically.

  2. Apply and demonstrate relevant facilitation competencies, skills, and orientations (including the Numinus care model) at an introductory level for the purposes of delivering psychedelic-assisted therapy.

  3. Describe the Numinus guiding principles within the context of integrative and transformative mental wellness as they relate to psychedelic-assisted therapy.

  4. Apply facilitation skills specific to psychedelic-assisted therapy during Preparation Sessions, Medicine Sessions, and Integration Sessions.

  5. Identify and respond to burnout, vicarious trauma, transference, and countertransference experienced by the health professional.

Applied Psychedelic-Assisted Therapy: Cases, Conditions, and Context

  1. Determine the symptoms and appropriate treatments for the conditions presented.

  2. Integrate different perspectives regarding assessment and treatment approaches applied to psychedelic-assisted therapy.

  3. Discuss key psychedelic-assisted therapy research and proposed therapeutic mechanisms.

  4. Apply best practices for preparation, medicine, and integration sessions.

  5. Assess client’s suitability for treatment according to relative and absolute contraindications.

  6. Identify potential challenges and risks associated with these disorders and limitations of psychedelic-assisted therapy as a brief intervention.

Molecular Foundations of MDMA

  1. Apply pharmacological knowledge of MDMA to the facilitation or development of a psychedelic-assisted therapy protocol in a clinical setting.

  2. Compare the wide range of effects, side effects, effects of long-term use, and abuse potential of MDMA.

  3. Apply cultural safety and humility to the administration of MDMA as part of psilocybin-assisted therapy in order to avoid cultural appropriation and cultural harm.

  4. Screen clients and determine if MDMA would be best suited for a given client or clinical presentation.

Course Structure

Before you will have a chance to complete the equivalency exam, you will review key concepts which you learned in your previous training as well as teach you about some core concepts that are specific to Numinus Training programs, such as the Numinus care model.

The equivalency exam will evaluate to what extent you have achieved the course learning outcomes, including knowledge, skills, and competencies, from the required prerequisites for Practical Applications. The exam will be divided into two parts:

  • Written exam (multiple choice and long-answer questions)
  • Reflection

For detailed instructions, please visit Equivalency Exam Instructions

Note

You will need to complete all review content prior to attempting the equivalency exam.